Autopsy report · NCT01303107

Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean

“The Sponsor has no interest in continuing the study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Cristália Produtos Químicos Farmacêuticos Ltda.

Sponsor type

Industry

Conditions

Cesarean Delivery

Interventions

Bupivacaine

Participants

0

Sites

2

Countries

Brazil

Trials that died the same way

• Manual Therapy/Exercises vs. Physiotherapy/Back School vs. Waiting List in Patients With Chronic Low Back Pain
  “Sponsor did not want to continue the study.” (84% match in meaning)
• ITT-5 Mechanisms of Spermatogenesis in Man
  “No funding was obtained for this study.” (79% match in meaning)
• ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
  “Currently no funding to continue study.” (77% match in meaning)
• Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
  “Sponsor elected not to continue with study.” (76% match in meaning)
• Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
  “Sponsor decided not to pursue study” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.